Impaired T cells and “memory-like” NK-cell reconstitution is linked to late-onset HCMV reactivation after letermovir cessation
Authors:
- Chris David LauruschkatCLChris David Lauruschkat
- Ihsan MuchsinIMIhsan Muchsin
- Alice Felicitas ReinARAlice Felicitas Rein
- Florian ErhardFEFlorian Erhard
- Lars DölkenLDLars Dölken
- Christine Susanne FalkCFChristine Susanne Falk
- Götz Ulrich GrigoleitGGGötz Ulrich Grigoleit
- Hermann EinseleHEHermann Einsele
- Sebastian WursterSWSebastian Wurster
Open Access
- 11 June 2024
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 8 (11) , 2967-2979
Abstract
Allogeneic hematopoietic stem cell transplantation (alloSCT) is the only cure for many hematologic malignancies. However, alloSCT recipients are susceptible to opportunistic pathogens, such as human cytomegalovirus (HCMV). Letermovir prophylaxis has revolutionized HCMV management, but the challenge of late HCMV reactivations has emerged. Immunological surrogates of clinically significant HCMV infection (csCMVi) after discontinuation of letermovir remain to be defined. Therefore, we studied natural killer (NK)-cell reconstitution along with the global and HCMV pp65-specific T-cell repertoire of 24 alloSCT recipients at 7 time points before (day +90) and after (days +120-270) cessation of letermovir prophylaxis. Patients who experienced csCMVi had lower counts of IFN-γ+ HCMV–specific CD4+ and CD8+ T cells than HCMV controllers. Furthermore, patients with csCMVi displayed late impairment of NK-cell reconstitution, especially suppression of “memory-like” CD159c+CD56dim NK-cell counts that preceded csCMVi events in most patients. Moreover, several surrogates of immune reconstitution were associated with the severity of HCMV manifestation, with patients suffering from HCMV end-organ disease and/or refractory HCMV infection harboring least HCMV–specific T cells and “memory-like” NK cells. Altogether, our findings establish an association of delayed or insufficient proliferation of both HCMV–specific T cells and “memory-like” NK cells with csCMVi and the severity of HCMV manifestations after discontinuation of letermovir prophylaxis.Keywords
This publication has 46 references indexed in Scilit:
- Adaptive NK cell response to human cytomegalovirus: Facts and open issuesSeminars in Immunology, 2022
- Adaptive NK cells undergo a dynamic modulation in response to human cytomegalovirus and recruit T cells in in vitro migration assaysBone Marrow Transplantation, 2022
- CD56dimCD57−NKG2C+ NK cells retaining proliferative potential are possible precursors of CD57+NKG2C+ memory-like NK cellsJournal of Leukocyte Biology, 2020
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell TransplantationNew England Journal of Medicine, 2017
- CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCTLeukemia, 2015
- Epigenetic Modification and Antibody-Dependent Expansion of Memory-like NK Cells in Human Cytomegalovirus-Infected IndividualsImmunity, 2015
- Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector FunctionImmunity, 2015
- Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell TransplantationNew England Journal of Medicine, 2014
- Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trialsJournal of Immunological Methods, 2007
- Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantationBone Marrow Transplantation, 2006